Status:
UNKNOWN
Effect of the Nutraceutical "MICODIGEST 2.0" on the Complications After Surgery for Colorectal Cancer
Lead Sponsor:
Fundacin Biomedica Galicia Sur
Conditions:
Colorectal Cancer
Surgery--Complications
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
Most of Colorectal cancer (CRC) diagnosed are candidates for surgical resection with curative intent, although colorectal surgery is associated with some complications that could be life-threatening. ...
Detailed Description
Colorectal cancer (CRC) is one of the most common malignancies in western countries. Most of the CRC diagnosed are candidates for surgical resection with curative intent. Cure rates after surgery vary...
Eligibility Criteria
Inclusion
- CRC patients who are candidates for surgical treatment with curative intent (risk I-III).
- American Society of Anesthesiologists' Physical Status Classification (ASA) \<3.
- Patients aged between 18 and 85 years.
- Eastern Cooperative Oncology Group (ECOG) scale between 0-2.
- Patients with preserved cognitive function.
- Patient's authorization after reading the study information sheet.
Exclusion
- Candidates for neoadjuvant therapy.
- Patients with concomitant carcinoma.
- Allergy to the supplied nutraceutical or presence of malabsorption syndrome.
- Presence of mental disorders
- Patient with active infection or antibiotic therapy in the last month.
- Previous colorectal surgery
Key Trial Info
Start Date :
April 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2022
Estimated Enrollment :
144 Patients enrolled
Trial Details
Trial ID
NCT04821258
Start Date
April 1 2021
End Date
September 1 2022
Last Update
March 29 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.